DESIGN OF THE FIRST PHASE 3 STUDY (REDWOOD) EVALUATING FAZIRSIRAN IN ADULTS WITH ALPHA-1 ANTITRYPSIN DEFICIENCY-ASSOCIATED LIVER DISEASE

被引：0
|
作者：
Gonzalez, Susana [1 ]
Wyman, Anne E. [1 ]
Strnad, Pavel [2 ]
Clark, Virginia [3 ]
Loomba, Rohit [4 ]
Strange, Charlie [5 ]
Teckman, Jeffrey [6 ]
Hoy, Michael [1 ]
Thakker, Paresh [1 ]
Wang, Lisi [1 ]
Marins, Ed G. [1 ]
Desai, Nirav K. [1 ]
机构：
[1] Takeda Dev Ctr Amer Inc, Cambridge, MA USA
[2] Univ Hosp Rwth Aachen, Aachen, Germany
[3] Univ Florida, Gainesville, FL USA
[4] Univ Calif San Diego, San Diego, CA USA
[5] Med Univ South Carolina, Charleston, SC USA
[6] St Louis Univ, St Louis, MO USA
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3312-A
引用
收藏
页码：S1494 / S1497
页数：4
相关论文
共 50 条
  • [1] RNAi therapeutics for diseases involving protein aggregation: fazirsiran for alpha-1 antitrypsin deficiency-associated liver disease
    Strnad, Pavel
    San Martin, Javier
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (07) : 571 - 581
  • [2] Patient experience of alpha-1 antitrypsin deficiency-associated liver disease: a qualitative study
    Clark, Virginia C.
    Park, Suna
    Krupnick, Robert
    Sparling, Nicole
    Ritchie, Jason
    Karki, Chitra
    Reynolds, Justin A.
    QUALITY OF LIFE RESEARCH, 2025,
  • [3] Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency
    Strnad, Pavel
    Mandorfer, Mattias
    Choudhury, Gourab
    Griffiths, William
    Trautwein, Christian
    Loomba, Rohit
    Schluep, Thomas
    Chang, Ting
    Yi, Min
    Given, Bruce D.
    Hamilton, James C.
    Martin, Javier San
    Teckman, Jeffery H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (06): : 514 - 524
  • [4] Proteomic analysis identified fazirsiran treatment-responsive protein biomarkers in patients with alpha-1 antitrypsin deficiency-associated liver disease
    Chuang, Jen-Chieh
    Hou, Ruixue
    Hong, Feng
    Cheng, Jie
    Paraskevopoulou, Maria D.
    Desai, Nirav K.
    Thakker, Paresh
    Martin, Javier San
    Schluep, Thomas
    Strnad, Pavel
    JOURNAL OF HEPATOLOGY, 2024, 80 : S698 - S698
  • [5] ALPHA-1 ANTITRYPSIN DEFICIENCY-ASSOCIATED LIVER DISEASE: A GLOBAL RETROSPECTIVE NATURAL HISTORY STUDY
    Strnad, Pavel
    Teckman, Jeffrey
    Turner, Alice
    Chuang, Jen-Chieh
    Hagiwara, May
    Karki, Chitra
    Marins, Ed G.
    Ren, Kaili
    Wyman, Anne E.
    Valladares, Angel
    Goldklang, Monica P.
    D'Armiento, Jeanine M.
    Clark, Virginia
    HEPATOLOGY, 2023, 78 : S1485 - S1486
  • [6] Evaluating Liver Disease in Alpha-1 Antitrypsin Deficiency (AATD)
    O'Meara, Fiachra
    Carty, Simon
    Fraughen, Daniel
    Carroll, Tomas
    Yousuf, Hassaan
    Gunaratnam, Cedric
    Ryan, John
    McElvaney, Noel G.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 : S172 - S173
  • [7] LONG- TERM SAFETY AND EFFICACY OF FAZIRSIRAN IN PATIENTS WITH ALPHA-1 ANTITRYPSIN DEFICIENCY-ASSOCIATED LIVER DISEASE ENROLLED IN THE PHASE 2 PLACEBO- CONTROLLED SEQUOIA TRIAL
    Clark, Virginia
    Strange, Charlie
    Strnad, Pavel
    Hamilton, James
    Zhou, Rong
    Schluep, Thomas
    Wyman, Anne
    Gonzalez, Susana
    Zhang, Yanwei
    Loomba, Rohit
    HEPATOLOGY, 2024, 80 : S1907 - S1908
  • [8] Quantitative measurement of the histological features of alpha-1 antitrypsin deficiency-associated liver disease in biopsy specimens
    Marek, George
    Collinsworth, Amy
    Liu, Chen
    Brantly, Mark
    Clark, Virginia
    PLOS ONE, 2021, 16 (08):
  • [9] Alpha-1 Antitrypsin Deficiency-Associated Chronic Obstructive Pulmonary Disease: A Family Perspective
    Anzueto, Antonio
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 12 (04) : 462 - 467
  • [10] Alpha-1 antitrypsin deficiency and liver disease
    Braillon, Alain
    Nguyen-Khac, Eric
    AMERICAN JOURNAL OF MEDICINE, 2008, 121 (06): : E25 - E25
12345